Mirum Pharmaceuticals Inc. (MIRM) Next Earnings Date & Options-Implied ±6.9% Move

$86.39 +0.68% NASDAQ • Public Delayed / 60s Snapshot

Mirum Pharmaceuticals Inc. (MIRM) carries a Roarable Rating of C (Hold) with 64/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.

ROARABLE C • HOLD / WATCH Cap $5.61B
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
RQD QUANT TACHOMETERHOLD / WATCH • C
025507510064
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw D+ · Rk B
Cash (13)Whales (10)SEC (16)Macro (13)CEO (12)
Each axis scored 0–20
12M PRICE TARGET CONE+2.7% Base Target
$137 Bull$89 Base$69 Bear
🔴 SUNDAY NIGHT PREP • 7:00 PM ET
WHALE OPTIONS TUG-OF-WAR:54% Call Buyers ($2.4M)
46% PutsMax Pain: $85.00
NEXT EST. REPORT: Dec 30, 2026 (~59 DAYS)

Options-Implied Post-Earnings ±6.9% Bell Curve

±$5.96 Expected Swing
$80.43 (-6.9%)Spot $86.39$92.35 (+6.9%)
TRADER CROWD SENTIMENT POLL

Will MIRM Beat & Rip or Miss Next Quarter?

Trailing EPS: $-0.36 • YoY Revenue Growth: 54.7%

51% Bullish Beat49% Bearish Miss

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

PeriodFiledRevenueNet ProfitFree Cash FlowGross Margin
FY 20252025-12-31$521.3M-$23.4M$54.9M44%
FY 20242024-12-31$336.9M-$87.9M$9.3M44%
FY 20232023-12-31$186.4M-$163.4M-$79.3M44%
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher + Guest Options & Prop-Trading Strategist

Whale Flow & Momentum Playbook: Trading MIRM & AI Leaders Without Chasing Tops

  • ✓Exact institutional whale strikes & implied earnings range on MIRM this week
  • ✓How active traders scale setups using funded prop-firm accounts instead of risking savings
  • ✓Free bonus: instant RQD Rating Flip alerts on all tracked momentum leaders
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
MIRM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -12.65%▼ DESCENDING CHANNEL
2026-10-30O $85.21H $87.49L $84.11C $85.00VOL 673.4K
RES: $98.34SUP: $73.02SMA50: $89.93SMA200: $98.57
$133.7$118.5$103.4$88.22$73.08RES $98.34SUP $73.02$85.002026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MIRM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
24.7%/yr Implied 5Y Growth

vs. +54.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MIRM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MIRM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for MIRM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

MIRM Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is MIRM's next earnings date?

Based on SEC filing cadence, Mirum Pharmaceuticals Inc. (MIRM)'s next quarterly earnings window is estimated around Dec 30, 2026.

How much is MIRM stock expected to move on earnings?

Options markets currently imply a ±6.9% post-earnings move for MIRM, projecting a trading range between $80.43 and $92.35.